| Targeting the BRAF V600E mutation in multiple myeloma M Andrulis, N Lehners, D Capper, R Penzel, C Heining, J Huellein, ... Cancer discovery 3 (8), 862-869, 2013 | 260 | 2013 |
| p53-dependent non-coding RNA networks in chronic lymphocytic leukemia CJ Blume, A Hotz-Wagenblatt, J Hüllein, L Sellner, A Jethwa, T Stolz, ... Leukemia 29 (10), 2015 | 190 | 2015 |
| Comprehensive genomic and transcriptomic analysis for guiding therapeutic decisions in patients with rare cancers P Horak, C Heining, S Kreutzfeldt, B Hutter, A Mock, J Hüllein, M Fröhlich, ... Cancer discovery 11 (11), 2780-2795, 2021 | 188 | 2021 |
| Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia CC Oakes, R Claus, L Gu, Y Assenov, J Hüllein, M Zucknick, M Bieg, ... Cancer discovery 4 (3), 348-361, 2014 | 164 | 2014 |
| Drug-perturbation-based stratification of blood cancer S Dietrich, M Oleś, J Lu, L Sellner, S Anders, B Velten, B Wu, J Huellein, ... The Journal of clinical investigation 128 (1), 427-445, 2018 | 161 | 2018 |
| BRAF inhibition in hairy cell leukemia with low-dose vemurafenib S Dietrich, A Pircher, V Endris, F Peyrade, CM Wendtner, GA Follows, ... Blood, The Journal of the American Society of Hematology 127 (23), 2847-2855, 2016 | 135 | 2016 |
| Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations BH Durham, B Getta, S Dietrich, J Taylor, H Won, JM Bogenberger, ... Blood, The Journal of the American Society of Hematology 130 (14), 1644-1648, 2017 | 116 | 2017 |
| The impact of SF3B1 mutations in CLL on the DNA-damage response GD te Raa, IAM Derks, V Navrkalová, A Skowronska, PD Moerland, ... Leukemia 29 (5), 1133-1142, 2015 | 111 | 2015 |
| TP53 mutation and survival in aggressive B cell lymphoma T Zenz, M Kreuz, M Fuge, W Klapper, H Horn, AM Staiger, D Winter, ... International Journal of Cancer 141 (7), 1381-1388, 2017 | 102 | 2017 |
| Recurrent CDKN1B (p27) mutations in hairy cell leukemia S Dietrich, J Hüllein, SCW Lee, B Hutter, D Gonzalez, S Jayne, MJS Dyer, ... Blood, The Journal of the American Society of Hematology 126 (8), 1005-1008, 2015 | 99 | 2015 |
| Continued response off treatment after BRAF inhibition in refractory hairy cell leukemia S Dietrich, J Hüllein, M Hundemer, N Lehners, A Jethwa, D Capper, ... Journal of Clinical Oncology 31 (19), e300-e303, 2013 | 76 | 2013 |
| Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia AC Leeksma, J Taylor, B Wu, JR Gardner, J He, M Nahas, M Gonen, ... Leukemia 33 (2), 390-402, 2019 | 65 | 2019 |
| Elucidation of tonic and activated B-cell receptor signaling in Burkitt’s lymphoma provides insights into regulation of cell survival J Corso, KT Pan, R Walter, C Doebele, S Mohr, H Bohnenberger, ... Proceedings of the National Academy of Sciences 113 (20), 5688-5693, 2016 | 57 | 2016 |
| Leflunomide induces apoptosis in fludarabine-resistant and clinically refractory CLL cells S Dietrich, OH Krämer, E Hahn, C Schäfer, T Giese, M Hess, T Tretter, ... Clinical cancer research 18 (2), 417-431, 2012 | 55 | 2012 |
| Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia J Lu, E Cannizzaro, F Meier-Abt, S Scheinost, PM Bruch, HAR Giles, ... Nature cancer 2 (8), 853-864, 2021 | 50 | 2021 |
| Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemia A Jethwa, J Hüllein, T Stolz, C Blume, L Sellner, A Jauch, M Sill, AP Kater, ... British journal of haematology 163 (4), 496-500, 2013 | 50 | 2013 |
| MED12 mutations and NOTCH signalling in chronic lymphocytic leukaemia B Wu, M Słabicki, L Sellner, S Dietrich, X Liu, A Jethwa, J Hüllein, ... British journal of haematology 179 (3), 421-429, 2017 | 48 | 2017 |
| Targeting the BRAF V600E mutation in multiple myeloma. Cancer Discov. 2013; 3: 862–869. doi: 10.1158/2159-8290 M Andrulis, N Lehners, D Capper, R Penzel, C Heining, J Huellein, ... CD-13-0014.[Abstract][CrossRef][Google Scholar], 0 | 40 | |
| Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers A Jahn, A Rump, TJ Widmann, C Heining, P Horak, B Hutter, ... Annals of Oncology 33 (11), 1186-1199, 2022 | 37 | 2022 |
| TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma A Jethwa, M Słabicki, J Hüllein, M Jentzsch, V Dalal, S Rabe, L Wagner, ... Blood, The Journal of the American Society of Hematology 131 (25), 2789-2802, 2018 | 37 | 2018 |
